Author, as appears in the article.: Saldivar-Espinoza, Bryan; Macip, Guillem; Pujadas, Gerard; Garcia-Vallve, Santiago
Department: Bioquímica i Biotecnologia
URV's Author/s: Garcia Vallve, Santiago / Macip Sancho, Guillem / Pujadas Anguiano, Gerard / Saldivar Espinoza, Bryan Percy
Keywords: Antibodies, viral Covid-19 Covid-19 vaccines Good health and well-being Humans Nucleocapsid Sars-cov-2
Thematic Areas: Antropologia / arqueologia Biotecnología Ciências ambientais Ciências biológicas i Ciências biológicas ii Ciências biológicas iii Enfermagem Engenharias iv Farmacia Infectious diseases Interdisciplinar Matemática / probabilidade e estatística Medicina i Medicina ii Medicina iii Medicina veterinaria Medicine (miscellaneous) Microbiology (medical) Odontología Saúde coletiva
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Author's mail: gerard.pujadas@urv.cat santi.garcia-vallve@urv.cat guillem.macip@estudiants.urv.cat guillem.macip@estudiants.urv.cat bryanpercy.saldivar@estudiants.urv.cat bryanpercy.saldivar@estudiants.urv.cat
Author identifier: 0000-0003-2598-8089 0000-0002-0348-7497 0000-0002-9667-2818 0000-0002-9667-2818
Record's date: 2025-02-24
Paper version: info:eu-repo/semantics/publishedVersion
Paper original source: International Journal Of Infectious Diseases. 125 231-232
APA: Saldivar-Espinoza, Bryan; Macip, Guillem; Pujadas, Gerard; Garcia-Vallve, Santiago (2022). Could nucleocapsid be a next-generation COVID-19 vaccine candidate?. International Journal Of Infectious Diseases, 125(), 231-232. DOI: 10.1016/j.ijid.2022.11.002
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Entity: Universitat Rovira i Virgili
Journal publication year: 2022
Publication Type: Journal Publications
Repositori URV